==Status== On March 13, 2007, the U.S. Food and Drug Administration (FDA) approved lapatinib in combination therapy for breast cancer patients already using capecitabine (Xeloda, Roche). In January 2010, Tykerb received accelerated approval for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overe...
Found on
http://en.wikipedia.org/wiki/Lapatinib
A type of targeted therapy, also known as Tyverb, and one of a group of cancer drugs called tyrosine kinase inhibitors (TKIs).
Found on
http://www.breastcancercare.org.uk/breast-cancer-information/glossary
A drug used with another anticancer drug to treat breast cancer that is HER2 positive and has advanced or metastasized (spread to other parts of the body) after treatment with other drugs. Lapatinib is also being studied in the treatment of other types of cancer. It is a type of ErbB-2 and EGFR dual tyrosine kinase inhibitor. Also called GW572016, ...
Found on
http://www.cancer.gov/dictionary?expand=L
No exact match found.
